This investigational study is enrolling moderate to severe COPD subjects.
To qualify you must be on inhaled maintenance medications and have required oral steroids 1-2 times or a hospitalization in the last year.
Pulmonary function test will be performed and compensation will be provided for those who qualify.
Subjects must be on triple therapy to qualify and will be switch to study provided Trelegy during the study. Study medication is a oral medication compared to placebo. Compensation will be provided to those who qualify. Please contact Monica Shutz at 314-514-8509.
Condition | Chronic Obstructive Lung Disease |
---|---|
Clinical Study Identifier | TX228636 |
Last Modified on | 23 November 2020 |
,
You have contacted , on
Your message has been sent to the study team at ,
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreEvery year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer
Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!
No annotations made yet
Congrats! You have your own personal workspace now.